123 related articles for article (PubMed ID: 19908916)
21. Design, synthesis and biological evaluation of tasiamide analogues as tumor inhibitors.
Zhang W; Sun T; Ma Z; Li Y
Mar Drugs; 2014 Apr; 12(4):2308-25. PubMed ID: 24759000
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins.
Chatzisideri T; Dalezis P; Leonidis G; Bousis S; Trafalis D; Bianchini F; Sarli V
Future Med Chem; 2021 May; 13(10):877-895. PubMed ID: 33858195
[TBL] [Abstract][Full Text] [Related]
23. Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides.
Zamora A; Gandioso A; Massaguer A; Buenestado S; Calvis C; Hernández JL; Mitjans F; Rodríguez V; Ruiz J; Marchán V
ChemMedChem; 2018 Sep; 13(17):1755-1762. PubMed ID: 29932312
[TBL] [Abstract][Full Text] [Related]
24. Minimal C-terminal modification boosts peptide self-assembling ability for necroptosis of cancer cells.
Feng Z; Wang H; Du X; Shi J; Li J; Xu B
Chem Commun (Camb); 2016 May; 52(37):6332-5. PubMed ID: 27087169
[TBL] [Abstract][Full Text] [Related]
25. Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity.
Fennell KA; Miller MJ
Org Lett; 2007 Apr; 9(9):1683-5. PubMed ID: 17397173
[TBL] [Abstract][Full Text] [Related]
26. [Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
Fonina LA; Az'muko AA; Kalikhevich VN; Levit ML; Ardemasova ZA; Gur'ianov SA; Belevskaia RG; Efremov MA; Treshchalina EM; Mikhaĭlova AA
Bioorg Khim; 2008; 34(4):451-6. PubMed ID: 18695716
[TBL] [Abstract][Full Text] [Related]
27. Versatile synthesis of new cytotoxic agents structurally related to hemiasterlins.
Simoni D; Lee RM; Durrant DE; Chi NW; Baruchello R; Rondanin R; Rullo C; Marchetti P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3431-5. PubMed ID: 20430617
[TBL] [Abstract][Full Text] [Related]
28. Alanine scan-guided synthesis and biological evaluation of analogues of culicinin D, a potent anticancer peptaibol.
Kavianinia I; Stubbing LA; Abbattista MR; Harris PWR; Smaill JB; Patterson AV; Brimble MA
Bioorg Med Chem Lett; 2020 Jun; 30(11):127135. PubMed ID: 32229061
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity studies of peptide-acridine/acridone conjugates.
Kukowska-Kaszuba M; Dzierzbicka K
Curr Med Chem; 2007; 14(29):3079-104. PubMed ID: 18220744
[TBL] [Abstract][Full Text] [Related]
30. Total synthesis and biological evaluation of tubulysin U, tubulysin V, and their analogues.
Balasubramanian R; Raghavan B; Begaye A; Sackett DL; Fecik RA
J Med Chem; 2009 Jan; 52(2):238-40. PubMed ID: 19102699
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment.
Yamashita A; Norton EB; Kaplan JA; Niu C; Loganzo F; Hernandez R; Beyer CF; Annable T; Musto S; Discafani C; Zask A; Ayral-Kaloustian S
Bioorg Med Chem Lett; 2004 Nov; 14(21):5317-22. PubMed ID: 15454219
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity of 2-aryl-1, 2, 4-triazolo[1, 5-a] pyridine derivatives.
Tao X; Hu Y
Med Chem; 2010 Mar; 6(2):65-9. PubMed ID: 20412047
[TBL] [Abstract][Full Text] [Related]
33. First total synthesis of prasinic acid and its anticancer activity.
Chakor N; Patil G; Writer D; Periyasamy G; Sharma R; Roychowdhury A; Mishra PD
Bioorg Med Chem Lett; 2012 Nov; 22(21):6608-10. PubMed ID: 23031589
[TBL] [Abstract][Full Text] [Related]
34. Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadening.
Bai R; Bates RB; Hamel E; Moore RE; Nakkiew P; Pettit GR; Sufi BA
J Nat Prod; 2002 Dec; 65(12):1824-9. PubMed ID: 12502322
[TBL] [Abstract][Full Text] [Related]
35. Epi-, epoxy-, and C2-modified bengamides: synthesis and biological evaluation.
Sarabia F; Martín-Gálvez F; García-Ruiz C; Sánchez-Ruiz A; Vivar-García C
J Org Chem; 2013 Jun; 78(11):5239-53. PubMed ID: 23647394
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.
Vivier M; Rapp M; Papon J; Labarre P; Galmier MJ; Sauzière J; Madelmont JC
J Med Chem; 2008 Feb; 51(4):1043-7. PubMed ID: 18237109
[TBL] [Abstract][Full Text] [Related]
37. Photocatalytic Tandem Radical Cyclization Enables Expeditious Total Synthesis of Epoxyhinokiol Analogues for Anticancer Activity Evaluation.
Xiao J; Wu H; Liang JR; Wu P; Guo C; Wang YW; Wang ZY; Peng Y
Org Lett; 2024 May; 26(17):3481-3486. PubMed ID: 38240748
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
39. A novel D-ring modified taxoid: synthesis and biological evaluation of a γ-lactone analogue of docetaxel.
Gao F; Yang ZK; Chen QH; Chen XG; Wang FP
Org Biomol Chem; 2012 Jan; 10(2):361-6. PubMed ID: 22080402
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
